EVOGENE LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.745 USD | -2.75% |
|
-9.14% | -11.31% |
| 23/05 | Earnings Flash (EVGN) EVOGENE Posts Q1 Revenue $4.2M, vs. Street Est of $3.5M | MT |
| 23/05 | Evogene Ltd. Provides Revenue Guidance for the Year 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 54.63B | - | |||||
| 39.92B | ||||||
| 26.86B | ||||||
| 26.22B | ||||||
| 18.78B | - |
